Company intelligence / Profile preview

Liaoning Nuovino Pharmaceutical

Benxi, Liaoning, China
Ownership
Private
Development stage
Other
01

Overview

Liaoning Nuovino Pharmaceutical is a China-based pharmaceutical enterprise dedicated to the research, development, and industrialization of innovative small molecule therapeutics and high-end generic drugs. Headquartered in the Benxi High-tech Industrial Development Zone, the company focuses on high-prevalence therapeutic areas including metabolic diseases, oncology, and cardiovascular disorders. Its lead clinical candidate, NVN-01, is a potent URAT1 inhibitor currently being evaluated for the treatment of hyperuricemia and gout. Nuovino maintains comprehensive in-house capabilities ranging from medicinal chemistry and process development to GMP-certified manufacturing of APIs and finished dosages. The company aims to provide affordable, high-quality medical solutions for patients globally while leveraging its strategic location in China's Medicine Capital.

Therapeutic areas
RheumatologyCardiovascularMetabolic DisordersOncology
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Liaoning Nuovino Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liaoning Nuovino Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call